TrialThe American journal on addictions2022

Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended-release naltrexone in a residential setting.

Paolo Mannelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.